{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:07:35Z","timestamp":1787785655290,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\"Pioneer\" and \"Leading Goose\" R&D Program of Zhejiang","award":["2025C02070"],"award-info":[{"award-number":["2025C02070"]}]},{"name":"\"Pioneer\" and \"Leading Goose\" R&D Program of Zhejiang","award":["2025C04007"],"award-info":[{"award-number":["2025C04007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171368"],"award-info":[{"award-number":["32171368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2023-PT320-02"],"award-info":[{"award-number":["2023-PT320-02"]}]},{"DOI":"10.13039\/501100011441","name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases","doi-asserted-by":"publisher","award":["zz202310"],"award-info":[{"award-number":["zz202310"]}],"id":[{"id":"10.13039\/501100011441","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Natural Science Foundation of China","award":["ZR2023ZD59"],"award-info":[{"award-number":["ZR2023ZD59"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03498-5","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:13:38Z","timestamp":1749082418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Advancing immunomodulation in organ transplantation: the therapeutic potential of self-assembled rapamycin nanoparticles in allograft rejection"],"prefix":"10.1186","volume":"23","author":[{"given":"Ruiqi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"3498_CR1","doi-asserted-by":"publisher","unstructured":"Sun R, Wang N, Zheng S, Wang H, Xie H. Nanotechnology-based Strategies for Molecular Imaging, Diagnosis, and Therapy of Organ Transplantation. Transplantation. Aug 1. 2024;108(8):1730\u20131748. https:\/\/doi.org\/10.1097\/tp.0000000000004913","DOI":"10.1097\/tp.0000000000004913"},{"issue":"5","key":"3498_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/liv.14091","volume":"39","author":"WA Dar","year":"2019","unstructured":"Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischaemia reperfusion injury in liver transplantation: cellular and molecular mechanisms. Liver Int May. 2019;39(5):788\u2013801. https:\/\/doi.org\/10.1111\/liv.14091.","journal-title":"Liver Int May"},{"issue":"5","key":"3498_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jhep.2021.07.027","volume":"75","author":"BT Lee","year":"2021","unstructured":"Lee BT, Fiel MI, Schiano TD. Antibody-mediated rejection of the liver allograft: an update and a clinico-pathological perspective. J Hepatol Nov. 2021;75(5):1203\u201316. https:\/\/doi.org\/10.1016\/j.jhep.2021.07.027.","journal-title":"J Hepatol Nov"},{"issue":"5","key":"3498_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/tp.0000000000002147","volume":"102","author":"M Charlton","year":"2018","unstructured":"Charlton M, Levitsky J, Aqel B, et al. International liver transplantation society consensus statement on immunosuppression in liver transplant recipients. Transplantation May. 2018;102(5):727\u201343. https:\/\/doi.org\/10.1097\/tp.0000000000002147.","journal-title":"Transplantation May"},{"issue":"5","key":"3498_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/SLA.0b013e3181896278","volume":"248","author":"M Vivarelli","year":"2008","unstructured":"Vivarelli M, Cucchetti A, La Barba G, et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Ann Surg Nov. 2008;248(5):857\u201362. https:\/\/doi.org\/10.1097\/SLA.0b013e3181896278.","journal-title":"Ann Surg Nov"},{"issue":"2","key":"3498_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41401-018-0070-2","volume":"40","author":"R Fu","year":"2019","unstructured":"Fu R, Tajima S, Suetsugu K, Watanabe H, Egashira N, Masuda S. Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacol Sin Feb. 2019;40(2):151\u20139. https:\/\/doi.org\/10.1038\/s41401-018-0070-2.","journal-title":"Acta Pharmacol Sin Feb"},{"issue":"4","key":"3498_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.trre.2018.07.001","volume":"32","author":"SA Acuna","year":"2018","unstructured":"Acuna SA. Etiology of increased cancer incidence after solid organ transplantation. Transplant Rev (Orlando) Oct. 2018;32(4):218\u201324. https:\/\/doi.org\/10.1016\/j.trre.2018.07.001.","journal-title":"Transplant Rev (Orlando) Oct"},{"issue":"1","key":"3498_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","volume":"59","author":"RN Saunders","year":"2001","unstructured":"Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int Jan. 2001;59(1):3\u201316. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00460.x.","journal-title":"Kidney Int Jan"},{"issue":"8","key":"3498_CR9","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/ajt.16505","volume":"21","author":"G Ehx","year":"2021","unstructured":"Ehx G, Ritacco C, Hannon M, et al. Comprehensive analysis of the Immunomodulatory effects of Rapamycin on human T cells in graft-versus-host disease prophylaxis. Am J Transplant Aug. 2021;21(8):2662\u201374. https:\/\/doi.org\/10.1111\/ajt.16505.","journal-title":"Am J Transplant Aug"},{"issue":"1","key":"3498_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.hbpd.2022.10.004","volume":"22","author":"GH Fan","year":"2023","unstructured":"Fan GH, Zhang CZ, Gao FQ, et al. A mixed blessing for liver transplantation patients - Rapamycin. Hepatobiliary Pancreat Dis Int Feb. 2023;22(1):14\u201321. https:\/\/doi.org\/10.1016\/j.hbpd.2022.10.004.","journal-title":"Hepatobiliary Pancreat Dis Int Feb"},{"issue":"4","key":"3498_CR11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/hep.23437","volume":"51","author":"C Toso","year":"2010","unstructured":"Toso C, Merani S, Bigam DL, Shapiro AM, Kneteman NM. Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology Apr. 2010;51(4):1237\u201343. https:\/\/doi.org\/10.1002\/hep.23437.","journal-title":"Hepatology Apr"},{"issue":"3","key":"3498_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2165\/00003495-200767030-00004","volume":"67","author":"JJ Augustine","year":"2007","unstructured":"Augustine JJ, Bodziak KA, Hricik DE. Use of sirolimus in solid organ transplantation. Drugs. 2007;67(3):369\u201391. https:\/\/doi.org\/10.2165\/00003495-200767030-00004.","journal-title":"Drugs"},{"key":"3498_CR13","doi-asserted-by":"publisher","first-page":"116865","DOI":"10.1016\/j.biopha.2024.116865","volume":"176","author":"MAJ van der Wagt","year":"2024","unstructured":"van der Wagt MAJ, Touw DJ, Dekkers BGJ. Poor solubility and stability of Rapamycin in aqueous environments. Biomed Pharmacother Jul. 2024;176:116865. https:\/\/doi.org\/10.1016\/j.biopha.2024.116865.","journal-title":"Biomed Pharmacother Jul"},{"key":"3498_CR14","doi-asserted-by":"publisher","unstructured":"Ben Brahim B, Arenas Hoyos I, Zhang L, V\u00f6gelin E, Olariu R, Rieben R. Tacrolimus-loaded drug delivery systems in vascularized composite allotransplantation: lessons and opportunities for local immunosuppression. Transplantation May. 2024;21. https:\/\/doi.org\/10.1097\/tp.0000000000005049.","DOI":"10.1097\/tp.0000000000005049"},{"issue":"4","key":"3498_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/tp.0000000000003032","volume":"104","author":"CG Yao","year":"2020","unstructured":"Yao CG, Martins PN. Nanotechnology applications in transplantation medicine. Transplantation Apr. 2020;104(4):682\u201393. https:\/\/doi.org\/10.1097\/tp.0000000000003032.","journal-title":"Transplantation Apr"},{"key":"3498_CR16","doi-asserted-by":"publisher","unstructured":"Zhao W, Yang Y, Song L, et al. A vesicular stomatitis Virus-Inspired DNA nanocomplex for ovarian Cancer therapy. Adv Sci (Weinh). Mar 2018;5(3):1700263. https:\/\/doi.org\/10.1002\/advs.201700263.","DOI":"10.1002\/advs.201700263"},{"issue":"8","key":"3498_CR17","doi-asserted-by":"publisher","first-page":"1600491","DOI":"10.1002\/advs.201600491","volume":"4","author":"Y Yang","year":"2017","unstructured":"Yang Y, Du T, Zhang J, et al. A 3D-Engineered conformal implant releases DNA nanocomplexs for eradicating the postsurgery residual glioblastoma. Adv Sci (Weinh) Aug. 2017;4(8):1600491. https:\/\/doi.org\/10.1002\/advs.201600491.","journal-title":"Adv Sci (Weinh) Aug"},{"issue":"1","key":"3498_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1039\/d2cs00437b","volume":"3","author":"H Li","year":"2023","unstructured":"Li H, Luo Q, Zhang H, et al. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev Jan. 2023;3(1):47\u201396. https:\/\/doi.org\/10.1039\/d2cs00437b.","journal-title":"Chem Soc Rev Jan"},{"key":"3498_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2020.08.043","volume":"10","author":"H Xie","year":"2020","unstructured":"Xie H, Zhu H, Zhou K, et al. Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival. J Control Release Dec. 2020;10:328:237\u201350. https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.043.","journal-title":"J Control Release Dec"},{"issue":"40","key":"3498_CR20","doi-asserted-by":"publisher","first-page":"36371","DOI":"10.1021\/acsami.9b11881","volume":"9","author":"T Kang","year":"2019","unstructured":"Kang T, Li Y, Wang Y, et al. Modular engineering of targeted Dual-Drug nanoassemblies for Cancer chemoimmunotherapy. ACS Appl Mater Interfaces Oct. 2019;9(40):36371\u201382. https:\/\/doi.org\/10.1021\/acsami.9b11881.","journal-title":"ACS Appl Mater Interfaces Oct"},{"key":"3498_CR21","doi-asserted-by":"publisher","first-page":"123742","DOI":"10.1016\/j.ijpharm.2023.123742","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ouyang Y, Yu L, et al. Novel approach for enhancing skin allograft survival by bioadhesive nanoparticles loaded with Rapamycin. Int J Pharm Feb. 2024;15:651:123742. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123742.","journal-title":"Int J Pharm Feb"},{"key":"3498_CR22","doi-asserted-by":"publisher","unstructured":"Ren Y, Dong X, Liu Y, et al. Rapamycin antagonizes angiogenesis and lymphangiogenesis through myeloid-derived suppressor cells in corneal transplantation. Am J Transpl. Sep 2023;23(9):1359\u201374. https:\/\/doi.org\/10.1016\/j.ajt.2023.05.017.","DOI":"10.1016\/j.ajt.2023.05.017"},{"issue":"1","key":"3498_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1039\/d0nh00469c","volume":"5","author":"X Chen","year":"2021","unstructured":"Chen X, Hu Z, Zhou L, Zhang F, Wan J, Wang H. Self-assembling a natural small molecular inhibitor that shows aggregation-induced emission and potentiates antitumor efficacy. Nanoscale Horiz Jan. 2021;5(1):33\u201342. https:\/\/doi.org\/10.1039\/d0nh00469c.","journal-title":"Nanoscale Horiz Jan"},{"issue":"12","key":"3498_CR24","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1111\/ajt.16748","volume":"21","author":"K Zhou","year":"2021","unstructured":"Zhou K, Chen X, Zhang L, et al. Targeting peripheral immune organs with self-assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection. Am J Transplant Dec. 2021;21(12):3871\u201382. https:\/\/doi.org\/10.1111\/ajt.16748.","journal-title":"Am J Transplant Dec"},{"issue":"3","key":"3498_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41565-021-01048-2","volume":"17","author":"JA Burke","year":"2022","unstructured":"Burke JA, Zhang X, Bobbala S, et al. Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of Rapamycin to enhance allogeneic islet graft viability. Nat Nanotechnol Mar. 2022;17(3):319\u201330. https:\/\/doi.org\/10.1038\/s41565-021-01048-2.","journal-title":"Nat Nanotechnol Mar"},{"issue":"12","key":"3498_CR26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/TP.0b013e3181fe5396","volume":"27","author":"G Kinnear","year":"2010","unstructured":"Kinnear G, Wood KJ, Marshall D, Jones ND. Anti-OX40 prevents effector T-cell accumulation and CD8\u2009+\u2009T-cell mediated skin allograft rejection. Transplantation Dec. 2010;27(12):1265\u201371. https:\/\/doi.org\/10.1097\/TP.0b013e3181fe5396.","journal-title":"Transplantation Dec"},{"key":"3498_CR27","doi-asserted-by":"publisher","first-page":"111289","DOI":"10.1016\/j.biopha.2021.111289","volume":"137","author":"X Song","year":"2021","unstructured":"Song X, Gao J, Liu H, Liu X, Tang K. Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function. Biomed Pharmacother May. 2021;137:111289. https:\/\/doi.org\/10.1016\/j.biopha.2021.111289.","journal-title":"Biomed Pharmacother May"},{"key":"3498_CR28","doi-asserted-by":"publisher","first-page":"8670280","DOI":"10.1155\/2017\/8670280","volume":"2017","author":"A Amouzegar","year":"2017","unstructured":"Amouzegar A, Chauhan SK. Effector and regulatory T cell trafficking in corneal allograft rejection. Mediators Inflamm. 2017;2017:8670280. https:\/\/doi.org\/10.1155\/2017\/8670280.","journal-title":"Mediators Inflamm"},{"issue":"3 Suppl","key":"3498_CR29","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/01.tp.0000153295.51565.f1","volume":"15","author":"J Pirenne","year":"2005","unstructured":"Pirenne J, Kitade H, Kawai M, et al. Regulatory cells, TH1\/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation Feb. 2005;15(3 Suppl):S25\u20137. https:\/\/doi.org\/10.1097\/01.tp.0000153295.51565.f1.","journal-title":"Transplantation Feb"},{"issue":"10","key":"3498_CR30","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1111\/ajt.17116","volume":"22","author":"R Dhital","year":"2022","unstructured":"Dhital R, Anand S, Graber B, et al. Murine cytomegalovirus promotes renal allograft inflammation via Th1\/17 cells and IL-17A. Am J Transplant Oct. 2022;22(10):2306\u201322. https:\/\/doi.org\/10.1111\/ajt.17116.","journal-title":"Am J Transplant Oct"},{"issue":"1","key":"3498_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bjh.16157","volume":"187","author":"S Elias","year":"2019","unstructured":"Elias S, Rudensky AY. Therapeutic use of regulatory T cells for graft-versus-host disease. Br J Haematol Oct. 2019;187(1):25\u201338. https:\/\/doi.org\/10.1111\/bjh.16157.","journal-title":"Br J Haematol Oct"},{"key":"3498_CR32","doi-asserted-by":"publisher","first-page":"535012","DOI":"10.3389\/fimmu.2021.535012","volume":"12","author":"X Ni","year":"2021","unstructured":"Ni X, Wang Q, Gu J, Lu L. Clinical and basic research progress on Treg-Induced immune tolerance in liver transplantation. Front Immunol. 2021;12:535012. https:\/\/doi.org\/10.3389\/fimmu.2021.535012.","journal-title":"Front Immunol"},{"issue":"2","key":"3498_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/TP.0b013e318200e97","volume":"27","author":"J Levitsky","year":"2011","unstructured":"Levitsky J, Gallon L, Miller J, et al. Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Transplantation Jan. 2011;27(2):199\u2013206. https:\/\/doi.org\/10.1097\/TP.0b013e318200e97.","journal-title":"Transplantation Jan"},{"issue":"27","key":"3498_CR34","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.3748\/wjg.v22.i27.6135","volume":"21","author":"R Fahrner","year":"2016","unstructured":"Fahrner R, Dondorf F, Ardelt M, Settmacher U, Rauchfuss F. Role of NK, NKT cells and macrophages in liver transplantation. World J Gastroenterol. Jul 2016;21(27):6135\u201344. https:\/\/doi.org\/10.3748\/wjg.v22.i27.6135.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3498_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.clim.2007.06.003","volume":"124","author":"SH Yang","year":"2007","unstructured":"Yang SH, Jin JZ, Lee SH, et al. Role of NKT cells in allogeneic islet graft survival. Clin Immunol Sep. 2007;124(3):258\u201366. https:\/\/doi.org\/10.1016\/j.clim.2007.06.003.","journal-title":"Clin Immunol Sep"},{"issue":"6","key":"3498_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/01.tp.0000280551.78156.ac","volume":"27","author":"JP Jukes","year":"2007","unstructured":"Jukes JP, Wood KJ, Jones ND. Natural killer T cells: a Bridge to tolerance or a pathway to rejection? Transplantation Sep. 2007;27(6):679\u201381. https:\/\/doi.org\/10.1097\/01.tp.0000280551.78156.ac.","journal-title":"Transplantation Sep"},{"issue":"3","key":"3498_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/tp.0000000000002022","volume":"102","author":"JR Scalea","year":"2018","unstructured":"Scalea JR, Lee YS, Davila E, Bromberg JS. Myeloid-Derived suppressor cells and their potential application in transplantation. Transplantation Mar. 2018;102(3):359\u201367. https:\/\/doi.org\/10.1097\/tp.0000000000002022.","journal-title":"Transplantation Mar"},{"issue":"6","key":"3498_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nri3227","volume":"25","author":"KJ Wood","year":"2012","unstructured":"Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol May. 2012;25(6):417\u201330. https:\/\/doi.org\/10.1038\/nri3227.","journal-title":"Nat Rev Immunol May"},{"issue":"3","key":"3498_CR39","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1038\/cddis.2017.86","volume":"23","author":"C Zhang","year":"2017","unstructured":"Zhang C, Wang S, Li J, et al. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury. Cell Death Dis Mar. 2017;23(3):e2695. https:\/\/doi.org\/10.1038\/cddis.2017.86.","journal-title":"Cell Death Dis Mar"},{"issue":"38","key":"3498_CR40","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.3748\/wjg.v23.i38.6962","volume":"14","author":"S Hamdani","year":"2017","unstructured":"Hamdani S, Thiolat A, Naserian S, et al. Delayed and short course of Rapamycin prevents organ rejection after allogeneic liver transplantation in rats. World J Gastroenterol Oct. 2017;14(38):6962\u201372. https:\/\/doi.org\/10.3748\/wjg.v23.i38.6962.","journal-title":"World J Gastroenterol Oct"},{"key":"3498_CR41","doi-asserted-by":"publisher","first-page":"20250","DOI":"10.1038\/srep20250","volume":"6","author":"T Wu","year":"2016","unstructured":"Wu T, Zhao Y, Wang H, et al. mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors. Sci Rep Feb 1. 2016;6:20250. https:\/\/doi.org\/10.1038\/srep20250.","journal-title":"Sci Rep Feb 1"},{"issue":"Pt B","key":"3498_CR42","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jcis.2023.07.087","volume":"15","author":"G Bordon","year":"2023","unstructured":"Bordon G, Ramakrishna SN, Edalat SG, et al. Liposomal aggregates sustain the release of Rapamycin and protect cartilage from friction. J Colloid Interface Sci Nov. 2023;15(Pt B):1659\u201370. https:\/\/doi.org\/10.1016\/j.jcis.2023.07.087.","journal-title":"J Colloid Interface Sci Nov"},{"issue":"48","key":"3498_CR43","doi-asserted-by":"publisher","first-page":"56909","DOI":"10.1021\/acsami.1c16530","volume":"8","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Cheng A, Jia Y, et al. pH-Responsive multifunctional theranostic Rapamycin-Loaded nanoparticles for imaging and treatment of acute ischemic stroke. ACS Appl Mater Interfaces Dec. 2021;8(48):56909\u201322. https:\/\/doi.org\/10.1021\/acsami.1c16530.","journal-title":"ACS Appl Mater Interfaces Dec"},{"key":"3498_CR44","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3389\/fimmu.2018.02283","volume":"9","author":"C Wei","year":"2018","unstructured":"Wei C, Wang Y, Ma L, et al. Rapamycin Nano-Micelle ophthalmic solution reduces corneal allograft rejection by potentiating Myeloid-Derived suppressor cells\u2019 function. Front Immunol. 2018;9:2283. https:\/\/doi.org\/10.3389\/fimmu.2018.02283.","journal-title":"Front Immunol"},{"issue":"1","key":"3498_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.apsb.2021.08.012","volume":"12","author":"S Fu","year":"2022","unstructured":"Fu S, Li G, Zang W, Zhou X, Shi K, Zhai Y. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharm Sin B Jan. 2022;12(1):92\u2013106. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.012.","journal-title":"Acta Pharm Sin B Jan"},{"issue":"5","key":"3498_CR46","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/med.21669","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang X, Li N, Zhang S, et al. Emerging carrier-free nanosystems based on molecular self-assembly of pure drugs for cancer therapy. Med Res Rev Sep. 2020;40(5):1754\u201375. https:\/\/doi.org\/10.1002\/med.21669.","journal-title":"Med Res Rev Sep"},{"issue":"3","key":"3498_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jconrel.2013.05.041","volume":"28","author":"DA Yardley","year":"2013","unstructured":"Yardley DA. nab-Paclitaxel mechanisms of action and delivery. J Control Release Sep. 2013;28(3):365\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.041.","journal-title":"J Control Release Sep"},{"issue":"12","key":"3498_CR48","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.7150\/thno.55250","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Xie B, Huang L, et al. Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy. Theranostics. 2021;11(12):5713\u201327. https:\/\/doi.org\/10.7150\/thno.55250.","journal-title":"Theranostics"},{"key":"3498_CR49","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bioactmat.2021.06.035","volume":"8","author":"H Mei","year":"2022","unstructured":"Mei H, Cai S, Huang D, Gao H, Cao J, He B. Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: from intrinsic physicochemical properties to external modification. Bioact Mater Feb. 2022;8:220\u201340. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.06.035.","journal-title":"Bioact Mater Feb"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03498-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03498-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03498-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:13:38Z","timestamp":1749082418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03498-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3498"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03498-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures adhered to the National Institute for the Care and Use of Laboratory Animals guidelines and were approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and the submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"418"}}